Milestone Pharmaceuticals (NasdaqGS:MIST) FY Conference Transcript

Milestone Pharmaceuticals (NasdaqGS:MIST) FY Conference September 09, 2025 12:00 PM ET Speaker0Alright. Good afternoon, everyone. Welcome to the afternoon session at day two of the Wainwright conference. I'm Brandon Fogs, one of the biopharma analysts here. Next up joining me for a fireside discussion is Milestone Pharmaceuticals.And joining me from the management team at Milestone is Joseph Olivetto, the CEO, and Lorenz Muller, the chief commercial officer. Thank you both for joining me. Joe, I guess, you ...